Abbott Laboratories
ABT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $44.3B | $42.0B | +5.7% |
| Operating income | $8.05B | $6.83B | +18.0% |
| Net income | $6.50B | $13.4B | −51.5% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $13.0B | $11.4B | +14.5% |
| Operating income | $1.36B | $2.06B | −34.0% |
| Net income | $920M | $1.64B | −44.0% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Abbott's revenue in FY2025?
- $44.3B in FY2025 (Fiscal year ended Dec 31, 2025), +5.7% vs $42.0B a year earlier, per its 10-K filed Feb 2026.
- Was Abbott profitable in FY2025?
- Yes: net income was $6.50B and operating income $8.05B in FY2025.
- What was Abbott's revenue in Q3 2026?
- $13.0B (+14.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.